Cipla recalls 4,800 bottles of anti-HIV tablets from American market
Nevirapine extended-release tablets, 400 mg in the 30-count bottle have been manufactured by Cipla at its Goa facility
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Home » Latest Updates » Page 102
Browsing Category
Latest Updates
SCHOTT KAISHA launches customisable prefillable glass syringes
The new glass syringes work with leading safety and autoinjector devices, meeting market demand for products that can be…
Ayush Ministry gives nod for Siddha dossier
The dossier on Siddha was in the making for several years under the Central Council for Research in Siddha
Being shorter is associated with increased mortality in critically ill patients: Study
The primary outcome was hospital mortality, adjusted for age, ethnicity, comorbid disease, severity of illness, socioeconomic…
Suven Life gets product patents from Brazil, Eurasia
The patents are valid through 2023 and 2034
DUSA Pharma awarded preliminary injunctive relief prohibiting Biofrontera from using its trade…
DUSA filed a motion for preliminary injunctive relief in November 2018 requesting an order prohibiting Biofrontera from using…
US FDA approves new protocol for study on Bayer’s birth control device
The study will now monitor here women implanted with the devices for five years, up from three years, and would need additional…
US FDA approves Stemline Therapeutics’ rare blood disease treatment
Elzonris will be commercially available in early 2019
Merck, Pfizer to end late-stage ovarian cancer treatment study
The setbacks come at a time when the drug is competing against other immunotherapy cancer drugs such as Merck & Co’s Keytruda,…
Aurobindo receives US FDA approval for Vecuronium Bromide injection
The product will be launched in Q4FY19